Notable Analyst Upgrades and Downgrades for Week of August 7 2023

 


 

Upgrades:



Curtiss-Wright (NYSE:CW) was upgraded by equities researchers at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Monday, FlyOnTheWall reports.

Several other equities research analysts also recently commented on the stock. Truist Financial upped their target price on shares of Curtiss-Wright from $190.00 to $211.00 and gave the company a “buy” rating in a research note on Friday, July 21st. Stifel Nicolaus increased their target price on Curtiss-Wright from $200.00 to $204.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. StockNews.com lowered shares of Curtiss-Wright from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. William Blair assumed coverage on shares of Curtiss-Wright in a research report on Friday, May 19th. They set an “outperform” rating for the company. Finally, Robert W. Baird boosted their price objective on shares of Curtiss-Wright from $200.00 to $228.00 and gave the company an “outperform” rating in a research report on Friday. Seven analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $200.20. Read more …



Jefferies Financial Group upgraded shares of Eli Lilly and Company (NYSE:LLY) from a hold rating to a buy rating in a research report report published on Tuesday, FlyOnTheWall reports.

Several other research analysts have also commented on LLY. Citigroup lifted their price objective on shares of Eli Lilly and Company from $360.00 to $525.00 and gave the stock a buy rating in a research note on Wednesday, July 26th. HSBC began coverage on Eli Lilly and Company in a research report on Friday, July 14th. They set a buy rating and a $560.00 target price for the company. SVB Securities lifted their target price on Eli Lilly and Company from $410.00 to $458.00 in a research report on Monday, May 1st. Bank of America lifted their target price on Eli Lilly and Company from $450.00 to $500.00 and gave the stock a buy rating in a research report on Wednesday, May 24th. Finally, Truist Financial lifted their price objective on Eli Lilly and Company from $430.00 to $525.00 and gave the company a buy rating in a report on Thursday, July 20th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, Eli Lilly and Company has a consensus rating of Moderate Buy and a consensus price target of $480.83. Read more ...



Southern (NYSE:SO) was upgraded by research analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating in a note issued to investors on Thursday, Briefing.com reports. The brokerage presently has a $69.00 target price on the utilities provider's stock, up from their prior target price of $60.00. Morgan Stanley's price objective points to a potential downside of 0.27% from the company's current price.

Several other equities research analysts have also recently weighed in on SO. Wells Fargo & Company dropped their price target on shares of Southern from $75.00 to $74.00 in a research report on Friday, August 4th. VNET Group reissued a "maintains" rating on shares of Southern in a research report on Friday, April 28th. StockNews.com lowered shares of Southern from a "hold" rating to a "sell" rating in a report on Tuesday, August 1st. LADENBURG THALM/SH SH initiated coverage on shares of Southern in a report on Wednesday. They issued a "buy" rating and a $72.00 price objective for the company. Finally, Guggenheim decreased their price objective on shares of Southern from $79.00 to $77.00 in a report on Friday, July 7th. Four analysts have rated the stock with a sell rating, three have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Southern presently has an average rating of "Hold" and an average price target of $74.07. Read more …




Essex Property Trust (NYSE:ESS) was upgraded by investment analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating in a research note issued to investors on Thursday, Briefing.com reports. The brokerage currently has a $247.00 price target on the real estate investment trust's stock, up from their prior price target of $208.00. Wells Fargo & Company's price target indicates a potential upside of 2.35% from the company's current price.

A number of other equities analysts have also recently issued reports on the company. StockNews.com began coverage on Essex Property Trust in a report on Thursday, May 18th. They set a "hold" rating on the stock. BMO Capital Markets cut Essex Property Trust from a "market perform" rating to an "underperform" rating and reduced their target price for the stock from $239.00 to $200.00 in a report on Monday, April 17th. Piper Sandler upgraded Essex Property Trust from a "neutral" rating to an "overweight" rating and raised their target price for the stock from $242.00 to $271.00 in a report on Monday, May 1st. Scotiabank upgraded Essex Property Trust from a "sector underperform" rating to a "sector outperform" rating and set a $240.00 target price on the stock in a report on Wednesday, April 12th. Finally, Royal Bank of Canada raised their target price on Essex Property Trust from $249.00 to $255.00 and gave the stock an "outperform" rating in a report on Monday, July 31st. Three analysts have rated the stock with a sell rating, twelve have given a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $244.60. Read more …



Cogent Communications (NASDAQ:CCOI) was upgraded by equities research analysts at TD Cowen from a “market perform” rating to an “outperform” rating in a research note issued to investors on Friday, Marketbeat.com reports. The brokerage currently has a $85.00 price objective on the technology company’s stock. TD Cowen’s price target would indicate a potential upside of 22.06% from the stock’s previous close.

A number of other brokerages also recently commented on CCOI. Bank of America upgraded Cogent Communications from an “underperform” rating to a “buy” rating and boosted their target price for the company from $45.00 to $85.00 in a research note on Wednesday, May 3rd. JPMorgan Chase & Co. downgraded Cogent Communications from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $72.00 to $70.00 in a research note on Monday, May 8th. StockNews.com initiated coverage on Cogent Communications in a research note on Thursday, May 18th. They issued a “hold” rating on the stock. Finally, 888 reissued a “reiterates” rating on shares of Cogent Communications in a report on Monday, May 22nd. Two analysts have rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $70.89. Read more …



Downgrades:



National Storage Affiliates Trust (NYSE:NSA) was downgraded by equities research analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating in a report issued on Tuesday, Briefing.com reports. They currently have a $35.00 price objective on the real estate investment trust's stock, down from their prior price objective of $47.00. Stifel Nicolaus' target price would suggest a potential upside of 6.22% from the stock's current price.

A number of other analysts have also recently weighed in on the company. Truist Financial dropped their price target on National Storage Affiliates Trust from $44.00 to $40.00 in a research report on Thursday, June 15th. Bank of America downgraded shares of National Storage Affiliates Trust from a "neutral" rating to an "underperform" rating and cut their price objective for the company from $48.00 to $38.00 in a research report on Monday, May 8th. StockNews.com began coverage on shares of National Storage Affiliates Trust in a research report on Thursday, May 18th. They issued a "hold" rating for the company. Wells Fargo & Company assumed coverage on National Storage Affiliates Trust in a report on Thursday, June 15th. They set an "underweight" rating and a $36.00 price target on the stock. Finally, Wolfe Research lowered National Storage Affiliates Trust from a "peer perform" rating to an "underperform" rating in a report on Wednesday, April 12th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, National Storage Affiliates Trust presently has an average rating of "Hold" and an average price target of $41.80. Read more …




Westlake (NYSE:WLK) was downgraded by investment analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating in a research note issued on Tuesday, Briefing.com reports. They presently have a $123.00 price target on the specialty chemicals company's stock, up from their prior price target of $120.00. JPMorgan Chase & Co.'s price objective indicates a potential downside of 8.16% from the stock's current price.

WLK has been the topic of several other reports. Citigroup assumed coverage on shares of Westlake in a research note on Tuesday, June 13th. They set a "neutral" rating and a $114.00 target price on the stock. StockNews.com started coverage on shares of Westlake in a research note on Thursday, May 18th. They issued a "hold" rating for the company. KeyCorp boosted their target price on shares of Westlake from $112.00 to $115.00 and gave the stock an "underweight" rating in a research note on Friday. Morgan Stanley reaffirmed an "equal weight" rating and set a $110.00 price objective on shares of Westlake in a research report on Wednesday, July 19th. Finally, Piper Sandler upgraded Westlake from a "neutral" rating to an "overweight" rating and set a $140.00 target price for the company in a research note on Tuesday, April 11th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $125.80. Read more ...



Celanese (NYSE:CE) was downgraded by stock analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a report released on Wednesday, Briefing.com reports. They presently have a $122.00 price objective on the basic materials company’s stock, down from their prior price objective of $135.00. JPMorgan Chase & Co.‘s target price indicates a potential downside of 2.72% from the company’s previous close.

CE has been the topic of several other research reports. Piper Sandler raised shares of Celanese from an “underweight” rating to a “neutral” rating and boosted their price target for the company from $105.00 to $120.00 in a report on Tuesday, April 11th. Morgan Stanley restated an “equal weight” rating and set a $110.00 target price on shares of Celanese in a research report on Wednesday, July 19th. BMO Capital Markets downgraded shares of Celanese from an “outperform” rating to a “market perform” rating and cut their target price for the company from $133.00 to $119.00 in a research report on Monday, June 26th. StockNews.com started coverage on shares of Celanese in a research report on Thursday, May 18th. They set a “sell” rating on the stock. Finally, Credit Suisse Group upped their target price on shares of Celanese from $100.00 to $111.00 and gave the company an “underperform” rating in a research report on Tuesday. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Celanese has a consensus rating of “Hold” and an average price target of $123.73. Read more …



United Parcel Service (NYSE:UPS) was downgraded by analysts at UBS Group from a “buy” rating to a “neutral” rating in a research note issued on Wednesday, Briefing.com reports. They currently have a $185.00 price objective on the transportation company’s stock, down from their prior price objective of $198.00. UBS Group’s target price points to a potential upside of 2.44% from the stock’s current price.

A number of other equities analysts have also recently commented on the company. Raymond James reduced their target price on United Parcel Service from $207.00 to $205.00 in a report on Wednesday, April 26th. Wolfe Research upgraded United Parcel Service from an “underperform” rating to a “market perform” rating in a report on Tuesday, April 25th. Stifel Nicolaus boosted their target price on United Parcel Service to $203.00 in a report on Wednesday, July 26th. BMO Capital Markets dropped their price target on shares of United Parcel Service from $185.00 to $180.00 in a research note on Wednesday, April 26th. Finally, Credit Suisse Group lowered shares of United Parcel Service from an “outperform” rating to a “neutral” rating and upped their target price for the stock from $200.00 to $204.00 in a research report on Monday, July 31st. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, United Parcel Service presently has a consensus rating of “Hold” and an average target price of $189.04. Read more …




Crown Castle (NYSE:CCI) was downgraded by stock analysts at Bank of America from a “buy” rating to a “neutral” rating in a report released on Thursday, MarketBeat Ratings reports. They presently have a $115.00 price target on the real estate investment trust’s stock. Bank of America‘s price objective would indicate a potential upside of 10.14% from the company’s current price.

CCI has been the topic of a number of other reports. Citigroup lowered their price target on shares of Crown Castle from $162.00 to $138.00 in a research note on Thursday, July 20th. TD Cowen lowered their price target on shares of Crown Castle from $152.00 to $149.00 and set an “outperform” rating on the stock in a research note on Friday, April 21st. Morgan Stanley lowered their price objective on shares of Crown Castle from $159.00 to $151.00 in a research note on Tuesday, April 18th. Raymond James lowered their price objective on shares of Crown Castle from $147.00 to $128.00 and set an “outperform” rating on the stock in a research note on Friday, July 21st. Finally, TheStreet cut shares of Crown Castle from a “b-” rating to a “c+” rating in a research note on Friday, May 12th. Two analysts have rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $138.67. Read more …



Medical Properties Trust (NYSE:MPW) was downgraded by analysts at Bank of America from a “neutral” rating to an “underperform” rating in a report issued on Friday, Marketbeat.com reports. They currently have a $8.00 target price on the real estate investment trust’s stock, down from their previous target price of $9.00. Bank of America‘s target price indicates a potential downside of 0.99% from the company’s previous close.

Several other brokerages also recently weighed in on MPW. StockNews.com initiated coverage on Medical Properties Trust in a report on Thursday, May 18th. They set a “hold” rating for the company. Wells Fargo & Company assumed coverage on Medical Properties Trust in a research report on Wednesday, April 19th. They issued an “equal weight” rating and a $9.00 target price on the stock. Finally, Stifel Nicolaus dropped their target price on Medical Properties Trust from $14.00 to $12.00 in a research report on Friday, April 28th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. According to MarketBeat, Medical Properties Trust presently has an average rating of “Hold” and an average price target of $12.92. Read more …



Stanley Black & Decker (NYSE:SWK) was downgraded by investment analysts at Wolfe Research from a “peer perform” rating to an “underperform” rating in a report issued on Friday, MarketBeat.com reports. They currently have a $94.00 price target on the industrial products company’s stock. Wolfe Research’s price target suggests a potential downside of 0.32% from the company’s previous close.

A number of other brokerages have also recently issued reports on SWK. StockNews.com upgraded Stanley Black & Decker from a “sell” rating to a “hold” rating in a research note on Monday, August 7th. Mizuho upped their price objective on Stanley Black & Decker from $90.00 to $100.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Robert W. Baird upped their price objective on Stanley Black & Decker from $85.00 to $92.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Citigroup upped their price objective on Stanley Black & Decker from $98.00 to $110.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Finally, Morgan Stanley upped their price objective on Stanley Black & Decker from $90.00 to $99.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 2nd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $96.00. Read more …



Archive of Upgrades and Downgrades


Comments